PROGREDUM GMBH -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 4.060.354 0 1
2020 0 6.085.800 285.200 3
2018 0 2.430.000 108.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM5
PERCUROS BV4
TECOBIOSCIENCES4
ASSOCIAZIONE HAND IN HAND3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
MEDRES MEDICAL RESEARCH3
UNIVERSITA DEGLI STUDI DI CAMERINO3
UNIVERSITa DEGLI STUDI DI NAPOLI 'FEDERICO II'3
ASSOCIAZIONE TOURISM2
DES SOLUTIO SOLUCOES E CONSULTORIA CIENTIFICA LDA2
HEINRICHHEINEUNIVERSITAET DUESSELDORF2
JENACELL2
TACIT BIO INNOVATION LIMITED2
THE UNIVERSITY OF SHEFFIELD2
ASSOCIAZIONE CULTURALE CASTELLI ROMANI GREEN TOUR1
AUGEAS ASSOCIAZIONE DI SPORT PROMOZIONE E TURISMO1
BOSCHIVA MELCHIORRI1
CHEMPRECISE CONSULTORIA BIOTECNOLOGIA PRODUTOS FARMACEUTICOS E IMOBILIARIO LDA1
CHIPDX IVS1
CLINICA MEDITERRANEA1
CONSIGLIO NAZIONALE DELLE RICERCHE1
DATAR CANCER GENETICS1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA1
FUJIFILM SONOSITE BV1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA1
GOOD BIOMARKER SCIENCES BV1
HAMMERSMITH MEDICINES RESEARCH1
HELRIK AND LOUW AND PARTNERS COMPANY1
HELRIK AND LOUW COMPANY1
HYLOMORPH1
INBIOSE1
INNOSO BV1
INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES1
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDIZINISCHE UNIVERSITAET WIEN1
NEMI TERRITORIO E TURISMO1
NUTRITION SCIENCES1
PHILIPPS UNIVERSITAET MARBURG1
RHEINISCHE FRIEDRICH WILHELMS UNIVERSITAET BONN1
SERANOVO BV1
SURGIMAB SAS1
TECHNICKA UNIVERZITA VO ZVOLENE1
TECHNISCHE UNIVERSITEIT DELFT1
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN1
THE UNIVERSITY OF EDINBURGH1
THE UNIVERSITY OF LIVERPOOL1
TISSUEGNOSTICS1
UNIVERSITAET INNSBRUCK1
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS1
UNIVERSITAT AUTONOMA DE BARCELONA1
UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJNAPOCA1
UNIVERSITE LOUIS PASTEUR STRASBOURG 11
UNIVERSITEIT GENT1
UNIVERSITEIT MAASTRICHT1
UNIVERSITEIT UTRECHT1
UNIVERSITEIT VAN AMSTERDAM1
UNIVERSITETET I STAVANGER1
UNIVERSITY OF GLASGOW1
UNIWERSYTET JAGIELLONSKI1
XENOPAT SL1

Constancy:

Total number of partners: 90
Partner loyalty:
Frequent Partner: (> 2 projects): 28
Rare Partner: 62
Frequent / Rare Partner Ratio: 0.45

Project overview:

Start dateProjectacronymrolefundingpartners
2022-09-01STOP SPREAD BAD BUGS: novel antimicrobial approaches to combat multidrug resistance in bacteria STOP SPREAD BAD BUGSparticipant4.060.35423
2020-05-01DevelOpmeNt of Cancer RNA TherapEutics cONCReTEparticipant2.060.80017
2020-05-01Staff Exchange for Novel applications in 19f magnetic resonance imaging SENATORparticipant1.541.00011
2020-04-01proactive monitoring of cancer as an alternative to surgery PRISAR2participant2.484.00025
2018-03-01Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life CANCERparticipant2.430.00019